Synthesis of fluorescent analogs of relaxin family peptides and their preliminary in vitro and in vivo characterization

Frontiers in Chemistry

Volumn 1, Issue , 2013, Pages

  Chan, Linda J ^a   Smith, Craig M ^a,b   Chua, Berenice E ^a   Lin, Feng ^a   Bathgate, Ross A D ^a,b   Separovic, Frances ^a   Gundlach, Andrew L ^a,b   Hossain, Mohammed Akhter ^a,b   Wade, John D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Brain; Click chemistry; Cy5.5 fluorophore; Relaxin; RXFP1; RXFP2

Indexed keywords

EID: 84987725301     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2013.00030     Document Type: Article

References (45)

1. Atherton, E., and Sheppard, R. C. (1998). Solid-Phase Peptide Synthesis: A Practical Approach. Oxford: IRL Press.
2. Bathgate, R. A. D., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., and Summers, R. J. (2013). Relaxin family peptides and their receptors. Physiol. Rev. 93, 405-480. doi: 10.1152/physrev.00001.2012
3. Bathgate, R. A. D., Lin, F., Hanson, N. F., Otvos, L. Jr., Guidolin, A., Giannakis, C., et al. (2006). Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 45, 1043-1053. doi: 10.1021/bi052233e
4. Best, M. D. (2009). Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. Biochemistry 48, 6571-6584. doi: 10.1021/bi9007726
5. Bogatcheva, N. V., Truong, A., Feng, S., Engel, W., Adham, I. M., and Agoulnik, A. I. (2003). GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol. Endocrinol. 17, 2639-2646. doi: 10.1210/me.2003-0096
6. Callander, G. E., Thomas, W. G., and Bathgate, R. A. D. (2009). Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment. Am. J. Physiol. Cell Physiol. 296, C1058-C1066. doi: 10.1152/ajpcell.00581.2008
7. Chan, L. J., Hossain, M. A., Samuel, C. S., Separovic, F., and Wade, J. D. (2011). The relaxin peptide family-structure, function and clinical applications. Protein. Pept. Lett. 18, 220-229. doi: 10.2174/092986611794578396
8. Chan, L. J., Rosengren, K. J., Layfield, S. L., Bathgate, R. A. D., Separovic, F., Samuel, C. S., et al. (2012). Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin. J. Biol. Chem. 287, 41152-41164. doi: 10.1074/jbc.M112.409284
9. Chen, W., Shields, T. S., Stork, P. J., and Cone, R. D. (1995). A colorimetric assay for measuring activation of Gs-and Gq-coupled signaling pathways. Anal. Biochem. 226, 349-354. doi: 10.1006/abio.1995.1235
10. Du, X. J., Bathgate, R. A. D., Samuel, C. S., Dart, A. M., and Summers, R. J. (2010). Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat. Rev. Cardiol. 7, 48-58. doi: 10.1038/nrcardio.2009.198
11. Ferlin, A., Arredi, B., Zuccarello, D., Garolla, A., Selice, R., and Foresta, C. (2006). Paracrine and endocrine roles of insulin-like factor 3. J. Endocrinol. Invest. 29, 657-664.
12. Ganella, D. E., Ryan, P. J., Bathgate, R. A. D., and Gundlach, A. L. (2012). Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications. Behav. Pharmacol. 23, 516-525. doi: 10.1097/FBP.0b013e3283576999
13. Gundlach, A. L., Ma, S., Sang, Q., Shen, P. J., Piccenna, L., Sedaghat, K., et al. (2009). Relaxin family peptides and receptors in mammalian brain. Ann. N.Y. Acad. Sci. 1160, 226-235. doi: 10.1111/j.1749-6632.2009.03956.x
14. Harland, D., Gardiner, S. M., and Bennett, T. (1988). Cardiovascular and dipsogenic effects of angiotensin II administered i.c.v. in Long-Evans and Brattleboro rats. Brain Res. 455, 58-64. doi: 10.1016/0006-8993(88)90114-X
15. Hisaw, F. L. (1926). Experimental relaxation of the pubis ligament of the guinea pig. Proc. Soc. Exp. Biol. Med. 23, 661-663. doi: 10.3181/00379727-23-3107
16. Hossain, M. A., Bathgate, R. A. D., Kong, C. K., Shabanpoor, F., Zhang, S., Haugaard-Jönsson, L. M., et al. (2008a). Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5). Chembiochem 9, 1816-1822. doi: 10.1002/cbic.200800113
17. Hossain, M. A., Rosengren, K. J., Haugaard-Jönsson, L. M., Zhang, S., Layfield, S., Ferraro, T., et al. (2008b). The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. J. Biol. Chem. 283, 17287-17297. doi: 10.1074/jbc.M801911200
18. Hossain, M. A., Belgi, A., Lin, F., Zhang, S., Shabanpoor, F., Chan, L., et al. (2009). Use of a temporary "solubilizing" peptide tag for the Fmoc solid-phase synthesis of human insulin glargine via use of regioselective disulfide bond formation. Bioconjug. Chem. 20, 1390-1396. doi: 10.1021/bc900181a
19. Hossain, M. A., Zhang, S., Lin, F., Ferraro, T., Bathgate, R. A. D., Tregear, G. W., et al. (2006). Regioselective disulfide solid phase synthesis, chemical characterization and in vitro receptor binding activity of equine relaxin. Int. J. Pept. Res. Ther. 12, 211-215. doi: 10.1007/s10989-006-9020-9
20. Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., et al. (2002). Activation of orphan receptors by the hormone relaxin. Science 295, 671-674. doi: 10.1126/science.1065654
21. Ionescu, I. A., Dine, J., Yen, Y. C., Buell, D. R., Herrmann, L., Holsboer, F., et al. (2012). Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons. Neuropsychopharmacology 37, 1323-1337. doi: 10.1038/npp.2011.317
22. Kamat, A. A., Feng, S., Bogatcheva, N. V., Truong, A., Bishop, C. E., and Agoulnik, A. I. (2004). Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology 145, 4712-4720. doi: 10.1210/en.2004-0515
23. Kolb, H. C., Finn, M. G., and Sharpless, K. B. (2001). Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. Engl. 40, 2004-2021. doi: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
24. Kumagai, J., Hsu, S. Y., Matsumi, H., Roh, J. S., Fu, P., Wade, J. D., et al. (2002). INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J. Biol. Chem. 277, 31283-31286. doi: 10.1074/jbc.C200398200
25. Ma, S., and Gundlach, A. L. (2007). Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies. Adv. Exp. Med. Biol. 612, 119-137. doi: 10.1007/978-0-387-74672-2_9
26. Ma, S., Olucha-Bordonau, F. E., Hossain, M. A., Lin, F., Kuei, C., Liu, C., et al. (2009). Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn. Mem. 16, 730-742. doi: 10.1101/lm.1438109
27. Ma, S., Roozendaal, B., Burazin, T. C. D., Tregear, G. W., McGaugh, J. L., and Gundlach, A. L. (2005). Relaxin receptor activation in the basolateral amygdala impairs memory consolidation. Eur. J. Neurosci. 22, 2117-2122. doi: 10.1111/j.1460-9568.2005.04374.x
28. 33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action? Neuroscience 141, 329-344. doi: 10.1016/j.neuroscience.2006.03.076
29. Mathieu, M. N., Wade, J. D., Catimel, B., Bond, C. P., Nice, E. C., Summers, R. J., et al. (2001). Synthesis, conformational studies and biological activity of N(alpha)-mono-biotinylated rat relaxin. J. Pept. Res. 57, 374-382. doi: 10.1034/j.1399-3011.2001.00853.x
30. McGowan, B. M., Minnion, J. S., Murphy, K. G., White, N. E., Roy, D., Stanley, S. A., et al. (2010). Central and peripheral administration of human relaxin-2 to adult male rats inhibits food intake. Diabetes Obes. Metab. 12, 1090-1096. doi: 10.1111/j.1463-1326.2010.01302.x
31. McGowan, B. M., Stanley, S. A., White, N. E., Spangeus, A., Patterson, M., Thompson, E. L., et al. (2007). Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am. J. Physiol. Endocrinol. Metab. 292, E913-E919. doi: 10.1152/ajpendo.00346.2006
32. McKinley, M. J., Burns, P., Colvill, L. M., Oldfield, B. J., Wade, J. D., Weisinger, R. S., et al. (1997). Distribution of Fos immunoreactivity in the lamina terminalis and hypothalamus induced by centrally administered relaxin in conscious rats. J. Neuroendocrinol. 9, 431-437. doi: 10.1046/j.1365-2826.1997.00600.x
33. Osheroff, P. L., and Phillips, H. S. (1991). Autoradiographic localization of relaxin binding sites in rat brain. Proc. Natl. Acad. Sci. U.S.A. 88, 6413-6417. doi: 10.1073/pnas.88.15.6413
34. Piccenna, L., Shen, P. J., Ma, S., Burazin, T. C. D., Gossen, J. A., Mosselman, S., et al. (2005). Localization of LGR7 gene expression in adult mouse brain using LGR7 knock-out/LacZ knock-in mice: correlation with LGR7 mRNA distribution. Ann. N.Y. Acad. Sci. 1041, 197-204. doi: 10.1196/annals.1282.030
35. Ryan, P. J., Buchler, E., Shabanpoor, F., Hossain, M. A., Wade, J. D., Lawrence, A. J., et al. (2013). Central relaxin-3 receptor (RXFP3) activation decreases anxiety-and depressive-like behaviours in the rat. Behav. Brain Res. 244, 142-151. doi: 10.1016/j.bbr.2013.01.034
36. Scott, D. J., Layfield, S., Yan, Y., Sudo, S., Hsueh, A. J., Tregear, G. W., et al. (2006). Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules. J. Biol. Chem. 281, 34942-34954. doi: 10.1074/jbc.M602728200
37. Sedaghat, K., Shen, P. J., Finkelstein, D. I., Henderson, J. M., and Gundlach, A. L. (2008). Leucine-rich repeat-containing G-protein-coupled receptor 8 in the rat brain: enrichment in thalamic neurons and their efferent projections. Neuroscience 156, 319-333. doi: 10.1016/j.neuroscience.2008.07.029
38. Shabanpoor, F., Bathgate, R. A. D., Belgi, A., Chan, L. J., Nair, V. B., Wade, J. D., et al. (2012). Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone. Biochem. Biophys. Res. Commun. 420, 253-256. doi: 10.1016/j.bbrc.2012.02.141
39. Shabanpoor, F., Hughes, R. A., Bathgate, R. A. D., Zhang, S., Scanlon, D. B., Lin, F., et al. (2008). Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions. Bioconjug. Chem. 19, 1456-1463. doi: 10.1021/bc800127p
40. Shabanpoor, F., Separovic, F., and Wade, J. D. (2009). The human insulin superfamily of polypeptide hormones. Vitam. Horm. 80, 1-31. doi: 10.1016/S0083-6729(08)00601-8
41. Summerlee, A. J., Hornsby, D. J., and Ramsey, D. G. (1998). The dipsogenic effects of rat relaxin: the effect of photoperiod and the potential role of relaxin on drinking in pregnancy. Endocrinology 139, 2322-2328. doi: 10.1210/en.139.5.2322
42. Sunn, N., Egli, M., Burazin, T. C. D., Burns, P., Colvill, L., Davern, P., et al. (2002). Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat. Proc. Natl. Acad. Sci. U.S.A. 99, 1701-1706. doi: 10.1073/pnas.022647699
43. Tanaka, M. (2010). Relaxin-3/insulin-like peptide 7, a neuropeptide involved in the stress response and food intake. FEBS J. 277, 4990-4997. doi: 10.1111/j.1742-4658.2010.07931.x
44. Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., et al. (2013). Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29-39. doi: 10.1016/S0140-6736(12)61855-8
45. Zhang, S., Lin, F., Hossain, M. A., Shabanpoor, F., Tregear, G. W., and Wade, J. D. (2008). Simultaneous post-cysteine(S-Acm) group removal quenching of iodine and isolation of peptide by one step ether precipitation. Int. J. Pept. Res. Ther. 14, 301-305. doi: 10.1007/s10989-008-9148-x